Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$259K Sell
500
-96
-16% -$48.6K 0.01% 358
2026
Q1
$295K Sell
596
-19
-3% -$8.96K 0.01% 324
2025
Q4
$262K Buy
615
+27
+5% +$11.6K 0.01% 335
2025
Q3
$279K Sell
588
-6
-1% -$2.84K 0.01% 324
2025
Q2
$279K Buy
594
+56
+10% +$25.6K 0.01% 303
2025
Q1
$251K Sell
538
-6
-1% -$2.7K 0.01% 307
2024
Q4
$228K Sell
544
-22
-4% -$10K 0.01% 309
2024
Q3
$270K Sell
566
-33
-6% -$15.1K 0.01% 290
2024
Q2
$263K Sell
599
-16
-3% -$7.04K 0.01% 287
2024
Q1
$286K Buy
+615
New +$266K 0.02% 261

Other funds holding LIN

Trilogy Capital's LIN Position: Q2 2026 in Review

Trilogy Capital reduced its Linde (LIN) stake by 16% in Q2 2026, selling an estimated $48.6K and leaving 500 shares worth $259K. The position accounts for 0.01% of the portfolio, ranked #358.

Trilogy Capital first reported a position in LIN in Q1 2024 and has held it in 10 quarters since. The position peaked at $295K in Q1 2026. 378 funds tracked by Wall St. Rank hold LIN as of Q2 2026.

  • Trilogy Capital held 500 shares of Linde worth $259K as of Q2 2026.
  • Trilogy Capital sold 96 Linde shares in Q2 2026, an estimated $48.6K.
  • Linde made up 0.01% of Trilogy Capital's portfolio in Q2 2026, its #358 holding.
  • Trilogy Capital first reported a position in Linde in Q1 2024 and has held it in 10 quarters since.
  • Trilogy Capital's Linde position peaked at $295K in Q1 2026.
  • 378 funds tracked by Wall St. Rank held Linde as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.